东富龙收盘上涨1.15%，滚动市盈率76.35倍，总市值114.18亿元

Company Overview - Dongfulong's closing price on August 7 was 14.91 yuan, with an increase of 1.15%, resulting in a rolling PE ratio of 76.35 times and a total market value of 11.418 billion yuan [1] - The company specializes in providing pharmaceutical process, core equipment, and overall engineering solutions for global pharmaceutical enterprises, with main products in the bioprocessing, formulation, engineering solutions, and food equipment sectors [1] Financial Performance - In the first quarter of 2025, Dongfulong reported operating revenue of 1.137 billion yuan, a year-on-year increase of 2.58%, while net profit was 20.1326 million yuan, reflecting a year-on-year decrease of 68.87%, with a sales gross margin of 24.45% [1] Industry Comparison - The average PE ratio for the medical device industry is 54.79 times, with a median of 37.86 times, placing Dongfulong at the 97th position in the industry ranking [1] - The company's static PE ratio is 58.83 times, and its price-to-book ratio is 1.46 times [2] Capital Flow - On August 7, Dongfulong experienced a net inflow of main funds amounting to 3.6885 million yuan, although it has seen a total outflow of 64.1225 million yuan over the past five days [1]